JSE drops as halted vaccine trial weighs on markets
The all share was down 0.41% and the top 40 0.35% in mid-morning trade
13 October 2020 - 11:57
The JSE was lower on Tuesday morning in line with European equities as concern about a halted Covid-19 vaccine trial weighed on markets.
At 10.45am, the JSE all share was down 0.41% to 55,326.81 points and the top 40 0.38%. Banks had lost 2.15% and financials 1.74%. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.